Based on our findings, it is likely that a FLCN-PGC-1α-TFAM signaling axis exists and that lack of FLCN expression may be an important feature in sporadic tumors of other organs as it is in BHDS-derived renal tumors. This evidence concerns the gene PPARGC1A and kidney neoplasm.